Results 51 to 60 of about 94,676 (365)
Evolutionary computational platform for the automatic discovery of nanocarriers for cancer treatment [PDF]
arXiv, 2021 We present the EVONANO platform for the evolution of nanomedicines with application to anti-cancer treatments. EVONANO includes a simulator to grow tumours, extract representative scenarios, and then simulate nanoparticle transport through these scenarios to predict nanoparticle distribution.
arxiv
Advances in MaterialsNanomedicines are extensively explored for cancer therapy. By delivering drug molecules more efficiently to pathological sites and by attenuating their accumulation in healthy organs and tissues, nanomedicine formulations aim to improve the balance ...
T. Lammers
semanticscholar +1 more source
Vaccines, 2021 COVID-19 vaccines have been developed with unprecedented speed which would not have been possible without decades of fundamental research on delivery nanotechnology.
T. H. Thi +5 more
semanticscholar +1 more source
International Journal of Nano Studies & Technology, 2016 The field of nanomedicine holds vast potential for the improvement of health care around the world and the coming nanomedical revolution will surely bring innovative solutions to many of the difficulties we currently encounter in the realm of patient treatment. Nanomedicine is a relatively new field for scientific inquiry.
Bharghava A +7 more
openaire +2 more sources
Nanomedicines for the Delivery of Biologics [PDF]
Pharmaceutics, 2019 A special symposium of the Academy of Pharmaceutical Sciences Nanomedicines Focus Group reviewed the current status of the use of nanomedicines for the delivery of biologics drugs. This meeting was particularly timely with the recent approval of the first siRNA-containing product Onpattro™ (patisiran), which is formulated as a lipid nanoparticle for ...
John Wahlich +10 more
openaire +7 more sources
Drug Delivery, 2018 Epithelial to mesenchymal transition (EMT) has emerged as a key process in the development of renal fibrosis. In fact, EMT-derived fibroblasts contribute to the progression of chronic renal disease.
Anna Sola +8 more
doaj +1 more source
Theranostics, 2020 Following its discovery more than 30 years ago, the enhanced permeability and retention (EPR) effect has become the guiding principle for cancer nanomedicine development.
Yang Shi +3 more
semanticscholar +1 more source
The Nanomedicines Alliance: An Industry Perspective on Nanomedicines
Journal of Nanomedicine & Nanotechnology, 2014 The field of nanomedicines has expanded significantly in recent years in the breadth of compounds under development as well as in the types of technology that are being applied to generate nanomedicines. The pathway to licensure of new nanomedicines is sufficiently well defined by existing regulations and guidance.
openaire +4 more sources
Introduction to Nanomedicine [PDF]
Molecules, 2015 Although mentions of nanoparticles in relation to biomedicine appeared in the late 1970s and are now the subject of over 10,000 publications per year, the term “Nanomedicine” only appeared at the turn of this century, and less than 30 papers including this term were published up to 2005. [...]
openaire +3 more sources
Bionanomedicine: A “Panacea” In Medicine?
Makara Journal of Health Research, 2017 Recent advances in nanotechnology, biotechnology, bioinformatics, and materials science have prompted novel developments in the field of nanomedicine. Enhancements in the theranostics, computational information, and management of diseases/disorders are ...
Dito Anurogo +2 more
doaj +1 more source